Mechanisms of Erythropoietin-induced Brain Protection in Neonatal Hypoxia-Ischemia Rat Model

Journal of Cerebral Blood Flow and Metabolism

Volumn 24, Issue 2, 2004, Pages 259-270

  Sun, Yun ^a   Zhou, Changman ^a   Polk, Paula ^b   Nanda, Anil ^a   Zhang, John H ^a  

^a Louisiana State University School of Medicine Shreveport   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Apoptosis; Brain injury; Heat shock protein; RT PCR

Indexed keywords

DNA FRAGMENT; HEAT SHOCK PROTEIN 27; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN HYPOXIA; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN WEIGHT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMISPHERE; IMMUNOHISTOCHEMISTRY; MORTALITY; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; WESTERN BLOTTING;

EID: 1042266617     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.WCB.0000110049.43905.AC     Document Type: Article

References (83)

1. Acs G, Acs P, Beckwith SM, Pitts RL, Clements E, Wong K, Verma A (2001) Erythropoietin and erythropoietin receptor expression in human cancer. Cancer Res. 61:3561-3565
2. Agnello D, Bigini P, Villa P, Mennini T, Cerami A, Brines ML, Ghezzi P (2002) Erythropoietin exerts an anti-inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitis. Brain Res. 952:128-134
3. Alafaci C, Salpietro F, Grasso G, Sfacteria A, Passalacqua M, Morabito A, Tripodo E, Calapai G, Buemi M, Tomasello F (2000) Effect of recombinant human erythropoietin on cerebral ischemia following experimental subarachnoid hemorrhage. Eur. J. Pharmacol. 406:219-225
4. Ashwal S, Pearce WJ (2001) Animal models of neonatal stroke. Curr. Opin. Pediatr. 13:506-516
5. Baciu I, Oprisiu C, Derevenco P, Vasile V, Muresan A, Hriscu M, Chis I (2000) The brain and other sites of erythropoietin production. Rom. J. Physiol 37:3-14
6. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR (2000) Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48:285-296
7. Bernaudin M, Marti HH, Roussel S, Divoux D, Nouvelot A, MacKenzie ET, Petit E (1999) A potential role for erythropoietin in focal permanent cerebral ischemia in mice. J. Cereb. Blood Flow Metab 19:643-651
8. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P (2002) Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab 22:393-403
9. Blomgren K, Zhu C, Wang X, Karlsson JO, Leverin AL, Bahr; BA, Mallard C, Hagberg H (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J. Biol. Chem. 276:10191-10198
10. Brines ML, Ghezzi P, Keenan S, Agnello D, de Lanerolle NC, Cerami C, Itri LM, Cerami A (2000) Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U.S.A 97:10526-10531
11. Brown JH, Maxwell AP, Doherty CC (1990) Subcutaneous erythropoietin therapy and hypertensive encephalopathy. Nephrol. Dial. Transplant. 5:553-554
12. Buemi M, Allegra A, Corica F, Floccari F, D'Avella D, Aloisi C, Calapai G, Iacopino G, Frisina N (2000) Intravenous recombinant erythropoietin does not lead to an increase in cerebrospinal fluid erythropoietin concentration. Nephrol. Dial. Transplant. 15:422-423
13. Buemi M, Aloisi C, Cavallaro E, Corica F, Floccari F, Grasso G, Lasco A, Pettinato G, Ruello A, Sturiale A, Frisina N (2002a) Recombinant human erythropoietin (rHuEPO): more than just the correction of uremic anemia. J. Nephrol. 15:97-103
14. Buemi M, Cavallaro E, Floccari F, Sturiale A, Aloisi C, Trimarchi M, Grasso G, Corica F, Frisina N (2002b) Erythropoietin and the brain: from neurodevelopment to neuroprotection. Clin. Sci. (Lond) 103:275-282
15. Buemi M, Cavallaro E, Floccari F, Sturiale A, Aloisi C, Trimarchi M, Corica F, Frisina N (2003) The pleiotropic effects of erythropoietin in the central nervous system. J. Neuropathol. Exp. Neurol. 62: 228-236
16. Calabrese V, Scapagnini G, Ravagna A, Giuffrida Stella AM, Butterfield DA (2002) Molecular chaperones and their roles in neural cell differentiation. Dev. Neurosci. 24:1-13
17. Calapai G, Marciano MC, Corica F, Allegra A, Parisi A, Frisina N, Caputi AP, Buemi M (2000) Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation. Eur. J. Pharmacol. 401:349-356
18. Calvert J, Yin W, Patel M, Badr A, Mychaskiw G, Parent A, Zhang J (2002) Hyperbaric oxygenation prevented brain injury induced by hypoxia-ischemia in a neonatal rat model. Brain Res. 951:1
19. Catania MA, Marciano MC, Parisi A, Sturiale A, Buemi M, Grasso G, Squadrito F, Caputi AP, Calapai G (2002) Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. Eur. J. Pharmacol. 437:147-150
20. Celik M, Gokmen N, Erbayraktar S, Akhisaroglu M, Konakc S, Ulukus C, Genc S, Genc K, Sagiroglu E, Cerami A, Brines M (2002) Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury. Proc. Natl. Acad. Sci. U.S.A 99:2258-2263
21. Cerami A (2001) Beyond erythropoiesis: novel applications for recombinant human erythropoietin. Semin. Hematol. 38:33-39
22. Chavez JC, LaManna JC (2002) Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J. Neurosci. 22: 8922-8931
23. Cheng Y, Deshmukh M, D'Costa A, Demaro JA, Gidday JM, Shah A, Sun Y, Jacquin MF, Johnson EM, Holtzman DM (1998) Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J. Clin. Invest 101:1992-1999
24. Chin K, Yu X, Beleslin-Cokic B, Liu C, Shen K, Mohrenweiser HW, Noguchi CT (2000) Production and processing of erythropoietin receptor transcripts in brain. Brain Res. Mol. Brain Res. 81:29-42
25. Chong ZZ, Kang JQ, Maiese K (2002a) Erythropoietin is a novel vascular protectant through activation of Aktl and mitochondrial modulation of cysteine proteases. Circulation 106:2973-2979
26. Chong ZZ, Kang JQ, Maiese K (2002b) Hematopoietic factor erythropoietin fosters neuroprotection through novel signal transduction cascades. J. Cereb. Blood Flow Metab 22:503-514
27. Dame C, Bartmann P, Wolber E, Fahnenstich H, Hofmann D, Fandrey J (2000) Erythropoietin gene expression in different areas of the developing human central nervous system. Brain Res. Dev. Brain Res. 125:69-74
28. Dame C, Juul SE, Christensen RD (2001) The biology of erythropoietin in the central nervous system and its neurotrophic and neuroprotective potential. Biol. Neonate 79:228-235
29. David RB, Lim GB, Moritz KM, Koukoulas I, Wintour EM (2002) Quantitation of the mRNA levels of Epo and EpoR in various tissues in the ovine fetus. Mol. Cell Endocrinol. 188:207-218
30. Del Toro J, Louis PT, Goddard-Finegold J (1991) Cerebrovascular regulation and neonatal brain injury. Pediatr. Neurol. 7:3-12
31. Digicaylioglu M, Bichet S, Marti HH, Wenger RH, Rivas LA, Bauer C, Gassmann M (1995) Localization of specific erythropoietin binding sites in defined areas of the mouse brain. Proc. Natl. Acad. Sci. U.S.A 92:3717-3720
32. Digicaylioglu M, Lipton SA (2001) Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-kappaB signalling cascades. Nature 412:641-647
33. Dwyer BE, Nishimura RN, Brown IR (1989) Synthesis of the major inducible heat shock protein in rat hippocampus after neonatal hypoxia-ischemia. Exp. Neurol. 104:28-31
34. Dzietko M, Felderhoff U, Bittigau P, Sifringer M, Hansen HH, Buehrer C, Ikonomidou C (2002) Erythropoietin Attenuates MK 801-Induced Neurodegeneration in the Developing Rat Brain. Program No. 821.2. 2002 Abstract Viewer/Itinerary Planner. Washington, DC: Society for Neuroscience. CD-ROM (Abstr.)
35. Eckardt KU (1995) The ontogeny of the biological role and production of erythropoietin. J. Perinat. Med. 23:19-29
36. Ehrenreich H, Hasselblatt M, Dembowski C, Cepek L, Lewczuk P, Stiefel M, Rustenbeck HH, Breiter N, Jacob S, Knerlich F, Bohn M, Poser W, Ruther E, Kochen M, Gefeller O, Gleiter C, Wessel TC, De Ryck M, ltri L, Prange H, Cerami A, Brines M, Siren AL (2002) Erythropoietin therapy for acute stroke is both safe and beneficial. Mol. Med. 8:495-505
37. Eid T, Brines M (2002) Recombinant human erythropoietin for neuroprotection: what is the evidence? Clin. Breast Cancer 3 Suppl 3:S109-S115
38. Fawke J, McIntyre J (2002) Recent advances in neonatology. Curr. Opin. Obstet. Gynecol. 14:153-158
39. Ferriero DM (2001) Oxidant mechanisms in neonatal hypoxia-ischemia. Dev. Neurosci. 23:198-202
40. Ferriero DM, Soberano HQ, Simon RP, Sharp FR (1990) Hypoxia-ischemia induces heat shock protein-like (HSP72) immunoreactivity in neonatal rat brain. Brain Res. Dev. Brain Res. 53:145-150
41. Fisher JW (2003) Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood.) 228:1-14
42. Gorio A, Gokmen N, Erbayraktar S, Yilmaz O, Madaschi L, Cichetti C, Di Giulio AM, Vardar E, Cerami A, Brines M (2002) Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma. Proc. Natl. Acad. Sci. U.S.A 99:9450-9455
43. Grasso G (2001) Neuroprotective effect of recombinant human erythropoietin in experimental subarachnoid hemorrhage. J. Neurosurg. Sci. 45:7-14
44. Grasso G, Passalacqua M, Sfacteria A, Conti A, Morabito A, Mazzullo G, De VG, Buemi M, Macri B, Tomasello F (2002) Does administration of recombinant human erythropoietin attenuate the increase of S-100 protein observed in cerebrospinal fluid after experimental subarachnoid hemorrhage? J. Neurosurg. 96:565-570
45. Grimm C, Wenzel A, Groszer M, Mayser H, Seeliger M, Samardzija M, Bauer C, Gassmann M, Reme CE (2002) HIF-1-induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8:718-724
46. Gubits RM, Burke RE, Casey-McIntosh G, Bandele A, Munell F (1993) Immediate early gene induction after neonatal hypoxia-ischemia. Brain Res. Mol. Brain Res. 18:228-238
47. Juul SE, Anderson DK, Li Y, Christensen RD (1998) Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 43:40-49
48. Juul SE (1999) Erythropoietin in the neonate. Curr. Probl. Pediatr. 29:129-149
49. Juul SE, Stallings SA, Christensen RD (1999a) Erythropoietin in the cerebrospinal fluid of neonates who sustained CNS injury. Pediatr. Res. 46:543-547
50. Juul SE, Yachnis AT, Rojiani AM, Christensen RD (1999b) Immunohistochemical localization of erythropoietin and its receptor in the developing human brain. Pediatr. Dev. Pathol. 2:148-158
51. Juul SE (2000) Nonerythropoietic roles of erythropoietin in the fetus and neonate. Clin. Perinatol. 27:527-541
52. Juul S (2002) Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Paediatr. Suppl 91:36-42
53. Kitagawa K, Matsumoto M, Hori M (2001) Protective and regenerative response endogenously induced in the ischemic brain. Can. J. Physiol Pharmacol. 79:262-265
54. Kogure K, Kato H (1993) Altered gene expression in cerebral ischemia. Stroke 24:2121-2127
55. Kumral A, Ozer E, Yilmaz O, Akhisaroglu M, Gokmen N, Duman N, Ulukus C, Genc S, Ozkan H (2003) Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats. Biol. Neonate 83:224-228
56. Lauterbach MD, Raz S, Sander CJ (2001) Neonatal hypoxic risk in preterm birth infants: the influence of sex and severity of respiratory distress on cognitive recovery. Neuropsychology. 15:411-420
57. Marti HH, Bernaudin M, Petit E, Bauer C (2000) Neuroprotection and Angiogenesis: Dual Role of Erythropoietin in Brain Ischemia. News Physiol Sci. 15:225-229
58. Matsushita H, Johnston MV, Lange MS, Wilson MA (2002) Protective Effect of Erythropoietin in Neonatal hypoxic ischemia. Program No. 697.10. 2002 Abstract Viewer/Itinerary Planner Washington, DC: Society for Neuroscience. CD-ROM. (Abstr.)
59. McLaughlin B, Hartnett KA, Erhardt JA, Legos JJ, White RF, Barone FC, Aizenman E (2003) Caspase 3 activation is essential for neuroprotection in preconditioning. Proc Natl Acad Sci 100:715-720.
60. Meguro T, Chen B, Lancon J, Zhang JH (2001a) Oxyhemoglobin induces caspase-mediated cell death in cerebral endothelial cells. J. Neurochem. 77:1128-1135
61. Meguro T, Chen B, Parent AD, Zhang JH (2001b) Caspase inhibitors attenuate oxyhemoglobin-induced apoptosis in endothelial cells. Stroke 32:561-566
62. Miao L, Dai Y, Zhang J (2002) Mechanism of RhoA/Rho kinase activation in endothelin-1- induced contraction in rabbit basilar artery. Am. J. Physiol Heart Circ. Physiol 283:H983-H989
63. Miller V (2000) Neonatal cerebral infarction. Semin. Pediatr. Neurol. 7:278-288
64. Munell F, Burke RE, Bandele A, Gubits RM (1994) Localization of c-fos, c-jun, and hsp70 mRNA expression in brain after neonatal hypoxia-ischemia. Brain Res. Dev. Brain Res. 77:111-121
65. Nowak TS, Jr., Jacewicz M (1994) The heat shock/stress response in focal cerebral ischemia. Brain Pathol. 4:67-76
66. Ogihara K, Zubkov AY, Parent AD, Zhang JH (2000) Oxyhemoglobin produces necrosis in cultured smooth muscle cells. Acta Neurochir. Suppl 76:507-510
67. Peterec SM (1995) Management of neonatal Rh disease. Clin. Perinatol. 22:561-592
68. Rice JE, III, Vannucci RC, Brierley JB (1981) The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann. Neurol. 9:131-141
69. Rollins S, Perkins E, Mandybur G, Zhang JH (2002) Oxyhemoglobin produces necrosis, not apoptosis, in astrocytes. Brain Res. 945:41-49
70. Rondon IJ, MacMillan LA, Beckman BS, Goldberg MA, Schneider T, Bunn HF, Malter JS (1991) Hypoxia up-regulates the activity of a novel erythropoietin mRNA binding protein. J. Biol. Chem. 266:16594-16598
71. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dimagl U, Meisel A (2002) Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22:10291-10301
72. Ruth V, Autti-Ramo I, Granstrom ML, Korkman M, Raivio KO (1988) Prediction of perinatal brain damage by cord plasma vasopressin, erythropoietin, and hypoxanthine values. J. Pediatr. 113:880-885
73. Sadamoto Y, Igase K, Sakanaka M, Sato K, Otsuka H, Sakaki S, Masuda S, Sasaki R (1998) Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. Biochem. Biophys. Res. Commun. 253:26-32
74. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R (1998) In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. U.S.A 95:4635-4640
75. Siren AL, Fratelli M, Brines M, Goemans C, Casagrande S, Lewczuk P, Keenan S, Gleiter C, Pasquali C, Capobianco A, Mennini T, Heumann R, Cerami A, Ehrenreich H, Ghezzi P (2001) Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress. Proc. Natl. Acad. Sci. U.S.A 98:4044-4049
76. Solaroglu I, Solaroglu A, Kaptanoglu E, Dede S, Haberal A, Beskonakli E, Kilinc K (2003) Erythropoietin prevents ischemia-reperfusion from inducing oxidative damage in fetal rat brain. Childs Nerv. Syst. 19:19-22
77. Sung JK, Miao L, Calvert JW, Huang L, Louis HH, Zhang JH (2003) A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Res. 959:29-38
78. Vannucci RC (1990) Current and potentially new management strategies for perinatal hypoxic-ischemic encephalopathy. Pediatrics 85:961-968
79. Vannucci RC, Vannucci SJ (1997) A model of perinatal hypoxic-ischemic brain damage. Ann. N.Y. Acad. Sci. 835:234-249
80. Wagner CL, Eicher DJ, Katikaneni LD, Barbosa E, Holden KR (1999) The use of hypothermia: a role in the treatment of neonatal asphyxia? Pediatr. Neurol. 21:429-443
81. Wanner RM, Spielmann P, Stroka DM, Camenisch G, Camenisch I, Scheid A, Houck DR, Bauer C, Gassmann M, Wenger RH (2000) Epolones induce erythropoietin expression via hypoxia-inducible factor-1 alpha activation. Blood 96:1558-1565
82. Wen TC, Sadamoto Y, Tanaka J, Zhu PX, Nakata K, Ma YJ, Hata R, Sakanaka M (2002) Erythropoietin protects neurons against chemical hypoxia and cerebral ischemic injury by up-regulating Bcl-xL expression. J. Neurosci. Res. 67:795-803
83. Xi G, Keep RF, Hua Y, Hoff JT (2000) Thrombin preconditioning, heat shock proteins and thrombin-induced brain edema. Acta Neurochir. Suppl 76:511-515